1. Home
  2. CODX vs CLIK Comparison

CODX vs CLIK Comparison

Compare CODX & CLIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • CLIK
  • Stock Information
  • Founded
  • CODX 2013
  • CLIK 2017
  • Country
  • CODX United States
  • CLIK Hong Kong
  • Employees
  • CODX N/A
  • CLIK N/A
  • Industry
  • CODX Medical/Dental Instruments
  • CLIK
  • Sector
  • CODX Health Care
  • CLIK
  • Exchange
  • CODX Nasdaq
  • CLIK NYSE
  • Market Cap
  • CODX 22.0M
  • CLIK N/A
  • IPO Year
  • CODX 2017
  • CLIK 2024
  • Fundamental
  • Price
  • CODX $0.35
  • CLIK $0.25
  • Analyst Decision
  • CODX Hold
  • CLIK
  • Analyst Count
  • CODX 1
  • CLIK 0
  • Target Price
  • CODX $1.00
  • CLIK N/A
  • AVG Volume (30 Days)
  • CODX 163.5K
  • CLIK 4.3M
  • Earning Date
  • CODX 05-08-2025
  • CLIK 02-14-2025
  • Dividend Yield
  • CODX N/A
  • CLIK N/A
  • EPS Growth
  • CODX N/A
  • CLIK N/A
  • EPS
  • CODX N/A
  • CLIK 0.07
  • Revenue
  • CODX $3,915,160.00
  • CLIK $6,051,074.00
  • Revenue This Year
  • CODX N/A
  • CLIK N/A
  • Revenue Next Year
  • CODX N/A
  • CLIK N/A
  • P/E Ratio
  • CODX N/A
  • CLIK $3.94
  • Revenue Growth
  • CODX N/A
  • CLIK 36.12
  • 52 Week Low
  • CODX $0.28
  • CLIK $0.16
  • 52 Week High
  • CODX $2.23
  • CLIK $4.39
  • Technical
  • Relative Strength Index (RSI)
  • CODX 42.44
  • CLIK N/A
  • Support Level
  • CODX $0.32
  • CLIK N/A
  • Resistance Level
  • CODX $0.38
  • CLIK N/A
  • Average True Range (ATR)
  • CODX 0.05
  • CLIK 0.00
  • MACD
  • CODX 0.01
  • CLIK 0.00
  • Stochastic Oscillator
  • CODX 60.87
  • CLIK 0.00

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: